The NPF funds cutting edge research on diseases of the pancreas.
ChiRhoClin, Inc. Announces Secretin Drug Shortage Resolved BURTONSVILLE, Md., July 28, 2015 /PRNewswire/ — During the past 5 years, ChiRhoClin, Inc. has worked directly with the Food and Drug Administration, CDER, the Drug Shortage Team, and the Office of Pharmaceutical Quality (OPQ) to resolve the shortage of ChiRhoStim® (Human Secretin for Injection). Today we received …
About the National Pancreas Foundation Here is a short video describing the work of our organization and the programs that we are developing to better serve the patients, physicians and researchers in our network. Please contact us at firstname.lastname@example.org if you would like to become more involved.